nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—DDC—Catecholamine biosynthesis—TH—prostate cancer	0.0198	0.0729	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—ASCL1—prostate cancer	0.0114	0.0418	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—ALDH1A2—prostate cancer	0.0107	0.0392	CbGpPWpGaD
Carbidopa—DDC—Dopamine metabolism—PRKACB—prostate cancer	0.00902	0.0332	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—AOX1—prostate cancer	0.00852	0.0313	CbGpPWpGaD
Carbidopa—DDC—Biogenic Amine Synthesis—ACHE—prostate cancer	0.00841	0.0309	CbGpPWpGaD
Carbidopa—DDC—Dopamine metabolism—NQO1—prostate cancer	0.00784	0.0288	CbGpPWpGaD
Carbidopa—DDC—Dopamine metabolism—TH—prostate cancer	0.00772	0.0284	CbGpPWpGaD
Carbidopa—Metyrosine—TH—prostate cancer	0.00719	0.402	CrCbGaD
Carbidopa—DDC—Biogenic Amine Synthesis—TH—prostate cancer	0.00689	0.0253	CbGpPWpGaD
Carbidopa—DDC—Amine-derived hormones—SLC5A5—prostate cancer	0.00687	0.0253	CbGpPWpGaD
Carbidopa—DDC—Dopamine metabolism—COMT—prostate cancer	0.00657	0.0242	CbGpPWpGaD
Carbidopa—DDC—Amine-derived hormones—TH—prostate cancer	0.00654	0.0241	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP7B1—prostate cancer	0.00628	0.0231	CbGpPWpGaD
Carbidopa—DDC—Biogenic Amine Synthesis—COMT—prostate cancer	0.00586	0.0215	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP6—prostate cancer	0.0054	0.0199	CbGpPWpGaD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—TH—prostate cancer	0.00526	0.0194	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—NKX3-1—prostate cancer	0.0045	0.0166	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—ZFHX3—prostate cancer	0.00432	0.0159	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP2C18—prostate cancer	0.00424	0.0156	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—TH—prostate cancer	0.00396	0.0146	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—HAO1—prostate cancer	0.00388	0.0143	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—TH—prostate cancer	0.00327	0.012	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP9—prostate cancer	0.00316	0.0116	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—CSAD—prostate cancer	0.00316	0.0116	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—ADI1—prostate cancer	0.00316	0.0116	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—TST—prostate cancer	0.00316	0.0116	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—PSAT1—prostate cancer	0.00316	0.0116	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—ASCL1—prostate cancer	0.00304	0.0112	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—GRHPR—prostate cancer	0.00294	0.0108	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—CKMT2—prostate cancer	0.00294	0.0108	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP2E1—prostate cancer	0.00288	0.0106	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP3A4—prostate cancer	0.00278	0.0102	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP1B1—prostate cancer	0.00273	0.0101	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—NAGLU—prostate cancer	0.00262	0.00963	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP19A1—prostate cancer	0.00257	0.00946	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—ID3—prostate cancer	0.00237	0.00871	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP1A1—prostate cancer	0.00207	0.00762	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—MTAP—prostate cancer	0.00204	0.00749	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	0.00196	0.00721	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—PHGDH—prostate cancer	0.00181	0.00668	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—ARG2—prostate cancer	0.00181	0.00668	CbGpPWpGaD
Carbidopa—Methyldopa—COMT—prostate cancer	0.00163	0.0908	CrCbGaD
Carbidopa—DDC—Circadian rythm related genes—HNF1B—prostate cancer	0.00146	0.00538	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—STAT3—prostate cancer	0.00135	0.00498	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP3—prostate cancer	0.00133	0.0049	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PRKDC—prostate cancer	0.0013	0.0048	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—MDM2—prostate cancer	0.00128	0.0047	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—TGFB1—prostate cancer	0.00125	0.00461	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—AHR—prostate cancer	0.00124	0.00458	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—PRKACB—prostate cancer	0.00124	0.00454	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.00115	0.00423	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.00107	0.00392	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—TH—prostate cancer	0.00106	0.00389	CbGpPWpGaD
Carbidopa—Mesalazine—MPO—prostate cancer	0.00103	0.0575	CrCbGaD
Carbidopa—Norepinephrine—SLC22A3—prostate cancer	0.000999	0.0558	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.000997	0.00367	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TOP2A—prostate cancer	0.000988	0.00364	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—SLC5A5—prostate cancer	0.000957	0.00352	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—NCOA2—prostate cancer	0.000951	0.0035	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.000949	0.00349	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—AR—prostate cancer	0.000941	0.00346	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—EZH2—prostate cancer	0.000938	0.00345	CbGpPWpGaD
Carbidopa—Dopamine—SLC22A3—prostate cancer	0.000929	0.0519	CrCbGaD
Carbidopa—DDC—Amino acid and derivative metabolism—NQO1—prostate cancer	0.000924	0.0034	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—TH—prostate cancer	0.000911	0.00335	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TH—prostate cancer	0.000864	0.00318	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000823	0.00303	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—EGR1—prostate cancer	0.000814	0.00299	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—NGFR—prostate cancer	0.000809	0.00298	CbGpPWpGaD
Carbidopa—Dopamine—COMT—prostate cancer	0.000794	0.0443	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.000761	0.0028	CbGpPWpGaD
Carbidopa—Norepinephrine—SLC22A1—prostate cancer	0.000717	0.04	CrCbGaD
Carbidopa—DDC—Metabolism—HAO1—prostate cancer	0.000712	0.00262	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—SIRT1—prostate cancer	0.000701	0.00258	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.000693	0.00255	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TYMS—prostate cancer	0.000679	0.0025	CbGpPWpGaD
Carbidopa—Dopamine—SLC22A1—prostate cancer	0.000666	0.0372	CrCbGaD
Carbidopa—Epinephrine—SLC22A1—prostate cancer	0.00065	0.0363	CrCbGaD
Carbidopa—DDC—Circadian rythm related genes—PPARA—prostate cancer	0.000582	0.00214	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ADI1—prostate cancer	0.00058	0.00213	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PSAT1—prostate cancer	0.00058	0.00213	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GRHL1—prostate cancer	0.00058	0.00213	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CSAD—prostate cancer	0.00058	0.00213	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CBR1—prostate cancer	0.00058	0.00213	CbGpPWpGaD
Carbidopa—DDC—Metabolism—TST—prostate cancer	0.00058	0.00213	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000566	0.00208	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—LEP—prostate cancer	0.000553	0.00203	CbGpPWpGaD
Carbidopa—Droxidopa—ADRB2—prostate cancer	0.000543	0.0303	CrCbGaD
Carbidopa—DDC—Metabolism—GRHPR—prostate cancer	0.000539	0.00198	CbGpPWpGaD
Carbidopa—DDC—Metabolism—UGT2B15—prostate cancer	0.000539	0.00198	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CKMT2—prostate cancer	0.000539	0.00198	CbGpPWpGaD
Carbidopa—DDC—Metabolism—UGT2B17—prostate cancer	0.000539	0.00198	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTM3—prostate cancer	0.000507	0.00187	CbGpPWpGaD
Carbidopa—DDC—Metabolism—MBTPS1—prostate cancer	0.000507	0.00187	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PGAM2—prostate cancer	0.000507	0.00187	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AOX1—prostate cancer	0.000507	0.00187	CbGpPWpGaD
Carbidopa—DDC—Metabolism—RFK—prostate cancer	0.000507	0.00187	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NAGLU—prostate cancer	0.000507	0.00187	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SULT2B1—prostate cancer	0.000507	0.00187	CbGpPWpGaD
Carbidopa—Isoprenaline—ADRB2—prostate cancer	0.000494	0.0276	CrCbGaD
Carbidopa—DDC—Metabolism—CYP3A43—prostate cancer	0.000481	0.00177	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AMACR—prostate cancer	0.000481	0.00177	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NAT1—prostate cancer	0.000481	0.00177	CbGpPWpGaD
Carbidopa—DDC—Metabolism—DEGS1—prostate cancer	0.000481	0.00177	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SRD5A2—prostate cancer	0.000481	0.00177	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—GSK3B—prostate cancer	0.000479	0.00176	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HSD17B1—prostate cancer	0.000459	0.00169	CbGpPWpGaD
Carbidopa—Norepinephrine—ADRB2—prostate cancer	0.000457	0.0255	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.00045	0.00165	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—SERPINE1—prostate cancer	0.000434	0.0016	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.00043	0.00158	CbGpPWpGaD
Carbidopa—Isoprenaline—CYP1A1—prostate cancer	0.000423	0.0236	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000415	0.00153	CbGpPWpGaD
Carbidopa—Epinephrine—ADRB2—prostate cancer	0.000415	0.0232	CrCbGaD
Carbidopa—DDC—Metabolism—HPGD—prostate cancer	0.000409	0.0015	CbGpPWpGaD
Carbidopa—DDC—Metabolism—B4GALT4—prostate cancer	0.000409	0.0015	CbGpPWpGaD
Carbidopa—Mesalazine—PTGS2—prostate cancer	0.000386	0.0216	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000386	0.00142	CbGpPWpGaD
Carbidopa—DDC—Metabolism—TNFRSF21—prostate cancer	0.000384	0.00141	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP7B1—prostate cancer	0.000374	0.00138	CbGpPWpGaD
Carbidopa—DDC—Metabolism—MTAP—prostate cancer	0.000374	0.00138	CbGpPWpGaD
Carbidopa—Dopamine—CYP2C19—prostate cancer	0.000366	0.0204	CrCbGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000365	0.00134	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SULT1E1—prostate cancer	0.000364	0.00134	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SRD5A1—prostate cancer	0.000364	0.00134	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ACSL4—prostate cancer	0.000348	0.00128	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HSD17B3—prostate cancer	0.000348	0.00128	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PHGDH—prostate cancer	0.000333	0.00123	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ARG2—prostate cancer	0.000333	0.00123	CbGpPWpGaD
Carbidopa—DDC—Metabolism—UMPS—prostate cancer	0.000333	0.00123	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PTEN—prostate cancer	0.00033	0.00121	CbGpPWpGaD
Carbidopa—DDC—Metabolism—LDHB—prostate cancer	0.000327	0.0012	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP3A5—prostate cancer	0.000321	0.00118	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—EP300—prostate cancer	0.000315	0.00116	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PDHA1—prostate cancer	0.00031	0.00114	CbGpPWpGaD
Carbidopa—DDC—Metabolism—UCP3—prostate cancer	0.00031	0.00114	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTA3—prostate cancer	0.00031	0.00114	CbGpPWpGaD
Carbidopa—DDC—Metabolism—TCN2—prostate cancer	0.00031	0.00114	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HSD3B1—prostate cancer	0.000296	0.00109	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SLC22A3—prostate cancer	0.000296	0.00109	CbGpPWpGaD
Carbidopa—DDC—Metabolism—TBXAS1—prostate cancer	0.000283	0.00104	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTA4—prostate cancer	0.000283	0.00104	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTA2—prostate cancer	0.000276	0.00102	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SULT1A1—prostate cancer	0.000273	0.001	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ABCG5—prostate cancer	0.000273	0.001	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTA1—prostate cancer	0.000266	0.00098	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NAT2—prostate cancer	0.000263	0.000969	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HSD3B2—prostate cancer	0.000263	0.000969	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTO1—prostate cancer	0.000263	0.000969	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000253	0.00093	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PLCB2—prostate cancer	0.000253	0.000929	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP2C18—prostate cancer	0.000253	0.000929	CbGpPWpGaD
Carbidopa—DDC—Metabolism—LRP2—prostate cancer	0.000253	0.000929	CbGpPWpGaD
Carbidopa—DDC—Metabolism—P4HB—prostate cancer	0.000248	0.000911	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SLC22A1—prostate cancer	0.000241	0.000886	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SULT2A1—prostate cancer	0.000235	0.000864	CbGpPWpGaD
Carbidopa—DDC—Metabolism—MED12—prostate cancer	0.000231	0.00085	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GNG5—prostate cancer	0.000229	0.000843	CbGpPWpGaD
Carbidopa—Epinephrine—CYP3A4—prostate cancer	0.000227	0.0127	CrCbGaD
Carbidopa—DDC—Circadian rythm related genes—TP53—prostate cancer	0.000225	0.000829	CbGpPWpGaD
Carbidopa—DDC—Metabolism—NCOA3—prostate cancer	0.000221	0.000812	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HPGDS—prostate cancer	0.000211	0.000775	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP2C19—prostate cancer	0.000209	0.00077	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—IL6—prostate cancer	0.000206	0.000759	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ACHE—prostate cancer	0.000204	0.000752	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTT1—prostate cancer	0.000204	0.000752	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP2A6—prostate cancer	0.000202	0.000743	CbGpPWpGaD
Carbidopa—Shock—Docetaxel—prostate cancer	0.0002	0.000282	CcSEcCtD
Carbidopa—Ill-defined disorder—Prednisone—prostate cancer	0.000199	0.000281	CcSEcCtD
Carbidopa—Thrombocytopenia—Docetaxel—prostate cancer	0.000199	0.00028	CcSEcCtD
Carbidopa—Rash—Estradiol—prostate cancer	0.000199	0.00028	CcSEcCtD
Carbidopa—Dermatitis—Estradiol—prostate cancer	0.000199	0.00028	CcSEcCtD
Carbidopa—Anaemia—Prednisone—prostate cancer	0.000199	0.00028	CcSEcCtD
Carbidopa—Confusional state—Capecitabine—prostate cancer	0.000198	0.000279	CcSEcCtD
Carbidopa—Headache—Estradiol—prostate cancer	0.000198	0.000278	CcSEcCtD
Carbidopa—Agitation—Prednisone—prostate cancer	0.000197	0.000278	CcSEcCtD
Carbidopa—Oedema—Capecitabine—prostate cancer	0.000197	0.000277	CcSEcCtD
Carbidopa—DDC—Metabolism—AKR1C3—prostate cancer	0.000196	0.000723	CbGpPWpGaD
Carbidopa—Angioedema—Prednisone—prostate cancer	0.000196	0.000276	CcSEcCtD
Carbidopa—Infection—Capecitabine—prostate cancer	0.000196	0.000275	CcSEcCtD
Carbidopa—DDC—Metabolism—PRKACB—prostate cancer	0.000195	0.000719	CbGpPWpGaD
Carbidopa—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000195	0.000275	CcSEcCtD
Carbidopa—Urticaria—Etoposide—prostate cancer	0.000194	0.000274	CcSEcCtD
Carbidopa—Haemoglobin—Epirubicin—prostate cancer	0.000194	0.000273	CcSEcCtD
Carbidopa—Anorexia—Docetaxel—prostate cancer	0.000194	0.000273	CcSEcCtD
Carbidopa—Malaise—Prednisone—prostate cancer	0.000194	0.000273	CcSEcCtD
Carbidopa—Shock—Capecitabine—prostate cancer	0.000194	0.000273	CcSEcCtD
Carbidopa—Rhinitis—Epirubicin—prostate cancer	0.000194	0.000272	CcSEcCtD
Carbidopa—Body temperature increased—Etoposide—prostate cancer	0.000193	0.000272	CcSEcCtD
Carbidopa—Abdominal pain—Etoposide—prostate cancer	0.000193	0.000272	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—prostate cancer	0.000193	0.000272	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP17A1—prostate cancer	0.000193	0.000711	CbGpPWpGaD
Carbidopa—Haemorrhage—Epirubicin—prostate cancer	0.000193	0.000272	CcSEcCtD
Carbidopa—Thrombocytopenia—Capecitabine—prostate cancer	0.000193	0.000271	CcSEcCtD
Carbidopa—Syncope—Prednisone—prostate cancer	0.000193	0.000271	CcSEcCtD
Carbidopa—Hypoaesthesia—Epirubicin—prostate cancer	0.000192	0.00027	CcSEcCtD
Carbidopa—Urinary tract disorder—Epirubicin—prostate cancer	0.000191	0.000268	CcSEcCtD
Carbidopa—Hyperhidrosis—Capecitabine—prostate cancer	0.00019	0.000268	CcSEcCtD
Carbidopa—Hypotension—Docetaxel—prostate cancer	0.00019	0.000267	CcSEcCtD
Carbidopa—Urethral disorder—Epirubicin—prostate cancer	0.000189	0.000266	CcSEcCtD
Carbidopa—Loss of consciousness—Prednisone—prostate cancer	0.000189	0.000266	CcSEcCtD
Carbidopa—Anorexia—Capecitabine—prostate cancer	0.000188	0.000264	CcSEcCtD
Carbidopa—Nausea—Estradiol—prostate cancer	0.000188	0.000264	CcSEcCtD
Carbidopa—Vomiting—Mitoxantrone—prostate cancer	0.000187	0.000263	CcSEcCtD
Carbidopa—Convulsion—Prednisone—prostate cancer	0.000186	0.000262	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—prostate cancer	0.000186	0.000261	CcSEcCtD
Carbidopa—Hypertension—Prednisone—prostate cancer	0.000185	0.000261	CcSEcCtD
Carbidopa—Rash—Mitoxantrone—prostate cancer	0.000185	0.000261	CcSEcCtD
Carbidopa—Dermatitis—Mitoxantrone—prostate cancer	0.000185	0.000261	CcSEcCtD
Carbidopa—Headache—Mitoxantrone—prostate cancer	0.000184	0.000259	CcSEcCtD
Carbidopa—DDC—Metabolism—NCOA2—prostate cancer	0.000184	0.000678	CbGpPWpGaD
Carbidopa—Hypotension—Capecitabine—prostate cancer	0.000184	0.000259	CcSEcCtD
Carbidopa—Insomnia—Docetaxel—prostate cancer	0.000184	0.000259	CcSEcCtD
Carbidopa—Paraesthesia—Docetaxel—prostate cancer	0.000183	0.000257	CcSEcCtD
Carbidopa—Anxiety—Prednisone—prostate cancer	0.000182	0.000257	CcSEcCtD
Carbidopa—Dyspnoea—Docetaxel—prostate cancer	0.000181	0.000255	CcSEcCtD
Carbidopa—Somnolence—Docetaxel—prostate cancer	0.000181	0.000254	CcSEcCtD
Carbidopa—Discomfort—Prednisone—prostate cancer	0.000181	0.000254	CcSEcCtD
Carbidopa—Hypersensitivity—Etoposide—prostate cancer	0.00018	0.000254	CcSEcCtD
Carbidopa—Haemoglobin—Doxorubicin—prostate cancer	0.00018	0.000253	CcSEcCtD
Carbidopa—Flushing—Epirubicin—prostate cancer	0.000179	0.000252	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—prostate cancer	0.000179	0.000252	CcSEcCtD
Carbidopa—Dyspepsia—Docetaxel—prostate cancer	0.000179	0.000252	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—prostate cancer	0.000179	0.000251	CcSEcCtD
Carbidopa—Insomnia—Capecitabine—prostate cancer	0.000178	0.000251	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—prostate cancer	0.000178	0.00025	CcSEcCtD
Carbidopa—Paraesthesia—Capecitabine—prostate cancer	0.000177	0.000249	CcSEcCtD
Carbidopa—Decreased appetite—Docetaxel—prostate cancer	0.000177	0.000249	CcSEcCtD
Carbidopa—Urinary tract disorder—Doxorubicin—prostate cancer	0.000176	0.000248	CcSEcCtD
Carbidopa—DDC—Metabolism—SLC5A5—prostate cancer	0.000176	0.000647	CbGpPWpGaD
Carbidopa—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000176	0.000247	CcSEcCtD
Carbidopa—Asthenia—Etoposide—prostate cancer	0.000176	0.000247	CcSEcCtD
Carbidopa—Dyspnoea—Capecitabine—prostate cancer	0.000176	0.000247	CcSEcCtD
Carbidopa—Oedema—Prednisone—prostate cancer	0.000175	0.000247	CcSEcCtD
Carbidopa—Fatigue—Docetaxel—prostate cancer	0.000175	0.000247	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—prostate cancer	0.000175	0.000246	CcSEcCtD
Carbidopa—Nausea—Mitoxantrone—prostate cancer	0.000175	0.000246	CcSEcCtD
Carbidopa—Infection—Prednisone—prostate cancer	0.000174	0.000245	CcSEcCtD
Carbidopa—Constipation—Docetaxel—prostate cancer	0.000174	0.000245	CcSEcCtD
Carbidopa—Pain—Docetaxel—prostate cancer	0.000174	0.000245	CcSEcCtD
Carbidopa—Dyspepsia—Capecitabine—prostate cancer	0.000173	0.000244	CcSEcCtD
Carbidopa—Pruritus—Etoposide—prostate cancer	0.000173	0.000244	CcSEcCtD
Carbidopa—Shock—Prednisone—prostate cancer	0.000173	0.000243	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP2E1—prostate cancer	0.000172	0.000632	CbGpPWpGaD
Carbidopa—Decreased appetite—Capecitabine—prostate cancer	0.000171	0.000241	CcSEcCtD
Carbidopa—Alopecia—Epirubicin—prostate cancer	0.000171	0.00024	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00017	0.000239	CcSEcCtD
Carbidopa—DDC—Metabolism—NQO1—prostate cancer	0.00017	0.000625	CbGpPWpGaD
Carbidopa—Fatigue—Capecitabine—prostate cancer	0.00017	0.000239	CcSEcCtD
Carbidopa—Hyperhidrosis—Prednisone—prostate cancer	0.00017	0.000239	CcSEcCtD
Carbidopa—Mental disorder—Epirubicin—prostate cancer	0.000169	0.000238	CcSEcCtD
Carbidopa—Pain—Capecitabine—prostate cancer	0.000168	0.000237	CcSEcCtD
Carbidopa—Constipation—Capecitabine—prostate cancer	0.000168	0.000237	CcSEcCtD
Carbidopa—Feeling abnormal—Docetaxel—prostate cancer	0.000168	0.000236	CcSEcCtD
Carbidopa—Diarrhoea—Etoposide—prostate cancer	0.000167	0.000236	CcSEcCtD
Carbidopa—DDC—Metabolism—TH—prostate cancer	0.000167	0.000616	CbGpPWpGaD
Carbidopa—Anorexia—Prednisone—prostate cancer	0.000167	0.000235	CcSEcCtD
Carbidopa—Gastrointestinal pain—Docetaxel—prostate cancer	0.000166	0.000234	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—prostate cancer	0.000166	0.000233	CcSEcCtD
Carbidopa—Flatulence—Epirubicin—prostate cancer	0.000166	0.000233	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP3A4—prostate cancer	0.000166	0.000609	CbGpPWpGaD
Carbidopa—Tension—Epirubicin—prostate cancer	0.000165	0.000232	CcSEcCtD
Carbidopa—Dysgeusia—Epirubicin—prostate cancer	0.000165	0.000232	CcSEcCtD
Carbidopa—Nervousness—Epirubicin—prostate cancer	0.000163	0.00023	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP1B1—prostate cancer	0.000163	0.000599	CbGpPWpGaD
Carbidopa—Back pain—Epirubicin—prostate cancer	0.000163	0.000229	CcSEcCtD
Carbidopa—Feeling abnormal—Capecitabine—prostate cancer	0.000162	0.000228	CcSEcCtD
Carbidopa—Dizziness—Etoposide—prostate cancer	0.000162	0.000228	CcSEcCtD
Carbidopa—Muscle spasms—Epirubicin—prostate cancer	0.000162	0.000227	CcSEcCtD
Carbidopa—Gastrointestinal pain—Capecitabine—prostate cancer	0.000161	0.000227	CcSEcCtD
Carbidopa—Abdominal pain—Docetaxel—prostate cancer	0.000161	0.000226	CcSEcCtD
Carbidopa—Body temperature increased—Docetaxel—prostate cancer	0.000161	0.000226	CcSEcCtD
Carbidopa—Insomnia—Prednisone—prostate cancer	0.000159	0.000223	CcSEcCtD
Carbidopa—Vision blurred—Epirubicin—prostate cancer	0.000158	0.000223	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—prostate cancer	0.000158	0.000222	CcSEcCtD
Carbidopa—DDC—Metabolism—GGT1—prostate cancer	0.000158	0.00058	CbGpPWpGaD
Carbidopa—Paraesthesia—Prednisone—prostate cancer	0.000157	0.000222	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—prostate cancer	0.000156	0.00022	CcSEcCtD
Carbidopa—Urticaria—Capecitabine—prostate cancer	0.000156	0.00022	CcSEcCtD
Carbidopa—Ill-defined disorder—Epirubicin—prostate cancer	0.000156	0.00022	CcSEcCtD
Carbidopa—Abdominal pain—Capecitabine—prostate cancer	0.000156	0.000219	CcSEcCtD
Carbidopa—Body temperature increased—Capecitabine—prostate cancer	0.000156	0.000219	CcSEcCtD
Carbidopa—Vomiting—Etoposide—prostate cancer	0.000156	0.000219	CcSEcCtD
Carbidopa—Anaemia—Epirubicin—prostate cancer	0.000155	0.000219	CcSEcCtD
Carbidopa—DDC—Metabolism—NCOA1—prostate cancer	0.000155	0.000571	CbGpPWpGaD
Carbidopa—Agitation—Epirubicin—prostate cancer	0.000154	0.000217	CcSEcCtD
Carbidopa—Dyspepsia—Prednisone—prostate cancer	0.000154	0.000217	CcSEcCtD
Carbidopa—Rash—Etoposide—prostate cancer	0.000154	0.000217	CcSEcCtD
Carbidopa—Dermatitis—Etoposide—prostate cancer	0.000154	0.000217	CcSEcCtD
Carbidopa—Headache—Etoposide—prostate cancer	0.000153	0.000216	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—prostate cancer	0.000153	0.000216	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP19A1—prostate cancer	0.000153	0.000563	CbGpPWpGaD
Carbidopa—Tension—Doxorubicin—prostate cancer	0.000153	0.000215	CcSEcCtD
Carbidopa—Decreased appetite—Prednisone—prostate cancer	0.000152	0.000215	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—prostate cancer	0.000152	0.000214	CcSEcCtD
Carbidopa—Malaise—Epirubicin—prostate cancer	0.000152	0.000213	CcSEcCtD
Carbidopa—Fatigue—Prednisone—prostate cancer	0.000151	0.000213	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—prostate cancer	0.000151	0.000213	CcSEcCtD
Carbidopa—Syncope—Epirubicin—prostate cancer	0.000151	0.000212	CcSEcCtD
Carbidopa—Leukopenia—Epirubicin—prostate cancer	0.00015	0.000212	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—prostate cancer	0.00015	0.000212	CcSEcCtD
Carbidopa—Constipation—Prednisone—prostate cancer	0.00015	0.000211	CcSEcCtD
Carbidopa—Hypersensitivity—Docetaxel—prostate cancer	0.00015	0.000211	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—prostate cancer	0.000149	0.00021	CcSEcCtD
Carbidopa—Palpitations—Epirubicin—prostate cancer	0.000148	0.000209	CcSEcCtD
Carbidopa—Loss of consciousness—Epirubicin—prostate cancer	0.000148	0.000208	CcSEcCtD
Carbidopa—DDC—Metabolism—RXRA—prostate cancer	0.000148	0.000543	CbGpPWpGaD
Carbidopa—Cough—Epirubicin—prostate cancer	0.000147	0.000206	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—prostate cancer	0.000147	0.000206	CcSEcCtD
Carbidopa—Asthenia—Docetaxel—prostate cancer	0.000146	0.000205	CcSEcCtD
Carbidopa—Convulsion—Epirubicin—prostate cancer	0.000146	0.000205	CcSEcCtD
Carbidopa—Nausea—Etoposide—prostate cancer	0.000145	0.000205	CcSEcCtD
Carbidopa—Hypertension—Epirubicin—prostate cancer	0.000145	0.000204	CcSEcCtD
Carbidopa—Hypersensitivity—Capecitabine—prostate cancer	0.000145	0.000204	CcSEcCtD
Carbidopa—Feeling abnormal—Prednisone—prostate cancer	0.000144	0.000203	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—prostate cancer	0.000144	0.000203	CcSEcCtD
Carbidopa—Pruritus—Docetaxel—prostate cancer	0.000144	0.000203	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—prostate cancer	0.000144	0.000202	CcSEcCtD
Carbidopa—Gastrointestinal pain—Prednisone—prostate cancer	0.000143	0.000202	CcSEcCtD
Carbidopa—Chest pain—Epirubicin—prostate cancer	0.000143	0.000201	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—prostate cancer	0.000143	0.000201	CcSEcCtD
Carbidopa—Anxiety—Epirubicin—prostate cancer	0.000143	0.000201	CcSEcCtD
Carbidopa—DDC—Metabolism—COMT—prostate cancer	0.000142	0.000523	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTP1—prostate cancer	0.000142	0.000521	CbGpPWpGaD
Carbidopa—Discomfort—Epirubicin—prostate cancer	0.000141	0.000199	CcSEcCtD
Carbidopa—Asthenia—Capecitabine—prostate cancer	0.000141	0.000199	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—prostate cancer	0.00014	0.000197	CcSEcCtD
Carbidopa—Dry mouth—Epirubicin—prostate cancer	0.00014	0.000197	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—prostate cancer	0.000139	0.000196	CcSEcCtD
Carbidopa—DDC—Metabolism—ITPR1—prostate cancer	0.000139	0.000513	CbGpPWpGaD
Carbidopa—Urticaria—Prednisone—prostate cancer	0.000139	0.000196	CcSEcCtD
Carbidopa—Pruritus—Capecitabine—prostate cancer	0.000139	0.000196	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—prostate cancer	0.000139	0.000196	CcSEcCtD
Carbidopa—Diarrhoea—Docetaxel—prostate cancer	0.000139	0.000196	CcSEcCtD
Carbidopa—Abdominal pain—Prednisone—prostate cancer	0.000139	0.000195	CcSEcCtD
Carbidopa—Body temperature increased—Prednisone—prostate cancer	0.000139	0.000195	CcSEcCtD
Carbidopa—Confusional state—Epirubicin—prostate cancer	0.000138	0.000195	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—prostate cancer	0.000137	0.000193	CcSEcCtD
Carbidopa—Oedema—Epirubicin—prostate cancer	0.000137	0.000193	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—prostate cancer	0.000137	0.000192	CcSEcCtD
Carbidopa—Infection—Epirubicin—prostate cancer	0.000136	0.000192	CcSEcCtD
Carbidopa—Cough—Doxorubicin—prostate cancer	0.000136	0.000191	CcSEcCtD
Carbidopa—Shock—Epirubicin—prostate cancer	0.000135	0.00019	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—prostate cancer	0.000135	0.00019	CcSEcCtD
Carbidopa—Diarrhoea—Capecitabine—prostate cancer	0.000135	0.00019	CcSEcCtD
Carbidopa—Dizziness—Docetaxel—prostate cancer	0.000134	0.000189	CcSEcCtD
Carbidopa—Thrombocytopenia—Epirubicin—prostate cancer	0.000134	0.000189	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—prostate cancer	0.000134	0.000189	CcSEcCtD
Carbidopa—Hyperhidrosis—Epirubicin—prostate cancer	0.000133	0.000187	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—prostate cancer	0.000132	0.000186	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—prostate cancer	0.000132	0.000186	CcSEcCtD
Carbidopa—DDC—Metabolism—TYMS—prostate cancer	0.000132	0.000484	CbGpPWpGaD
Carbidopa—Discomfort—Doxorubicin—prostate cancer	0.000131	0.000184	CcSEcCtD
Carbidopa—Anorexia—Epirubicin—prostate cancer	0.000131	0.000184	CcSEcCtD
Carbidopa—Dizziness—Capecitabine—prostate cancer	0.00013	0.000183	CcSEcCtD
Carbidopa—DDC—Metabolism—GSTM1—prostate cancer	0.00013	0.000479	CbGpPWpGaD
Carbidopa—Dry mouth—Doxorubicin—prostate cancer	0.000129	0.000182	CcSEcCtD
Carbidopa—Vomiting—Docetaxel—prostate cancer	0.000129	0.000182	CcSEcCtD
Carbidopa—Hypersensitivity—Prednisone—prostate cancer	0.000129	0.000182	CcSEcCtD
Carbidopa—Rash—Docetaxel—prostate cancer	0.000128	0.00018	CcSEcCtD
Carbidopa—Hypotension—Epirubicin—prostate cancer	0.000128	0.00018	CcSEcCtD
Carbidopa—Dermatitis—Docetaxel—prostate cancer	0.000128	0.00018	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—prostate cancer	0.000128	0.00018	CcSEcCtD
Carbidopa—DDC—Metabolism—LPL—prostate cancer	0.000128	0.00047	CbGpPWpGaD
Carbidopa—Headache—Docetaxel—prostate cancer	0.000127	0.000179	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—prostate cancer	0.000127	0.000179	CcSEcCtD
Carbidopa—Infection—Doxorubicin—prostate cancer	0.000126	0.000177	CcSEcCtD
Carbidopa—Asthenia—Prednisone—prostate cancer	0.000126	0.000177	CcSEcCtD
Carbidopa—Vomiting—Capecitabine—prostate cancer	0.000125	0.000176	CcSEcCtD
Carbidopa—Shock—Doxorubicin—prostate cancer	0.000125	0.000176	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—prostate cancer	0.000124	0.000175	CcSEcCtD
Carbidopa—Rash—Capecitabine—prostate cancer	0.000124	0.000175	CcSEcCtD
Carbidopa—Pruritus—Prednisone—prostate cancer	0.000124	0.000175	CcSEcCtD
Carbidopa—Insomnia—Epirubicin—prostate cancer	0.000124	0.000175	CcSEcCtD
Carbidopa—Dermatitis—Capecitabine—prostate cancer	0.000124	0.000175	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP1A1—prostate cancer	0.000123	0.000454	CbGpPWpGaD
Carbidopa—Headache—Capecitabine—prostate cancer	0.000123	0.000174	CcSEcCtD
Carbidopa—Paraesthesia—Epirubicin—prostate cancer	0.000123	0.000173	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—prostate cancer	0.000123	0.000173	CcSEcCtD
Carbidopa—DDC—Metabolism—ERCC2—prostate cancer	0.000122	0.00045	CbGpPWpGaD
Carbidopa—Dyspnoea—Epirubicin—prostate cancer	0.000122	0.000172	CcSEcCtD
Carbidopa—Somnolence—Epirubicin—prostate cancer	0.000122	0.000172	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—prostate cancer	0.000121	0.00017	CcSEcCtD
Carbidopa—Nausea—Docetaxel—prostate cancer	0.000121	0.00017	CcSEcCtD
Carbidopa—Dyspepsia—Epirubicin—prostate cancer	0.000121	0.00017	CcSEcCtD
Carbidopa—Diarrhoea—Prednisone—prostate cancer	0.00012	0.000169	CcSEcCtD
Carbidopa—Decreased appetite—Epirubicin—prostate cancer	0.000119	0.000168	CcSEcCtD
Carbidopa—Hypotension—Doxorubicin—prostate cancer	0.000119	0.000167	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000118	0.000167	CcSEcCtD
Carbidopa—Fatigue—Epirubicin—prostate cancer	0.000118	0.000166	CcSEcCtD
Carbidopa—Pain—Epirubicin—prostate cancer	0.000117	0.000165	CcSEcCtD
Carbidopa—Constipation—Epirubicin—prostate cancer	0.000117	0.000165	CcSEcCtD
Carbidopa—Nausea—Capecitabine—prostate cancer	0.000117	0.000165	CcSEcCtD
Carbidopa—Dizziness—Prednisone—prostate cancer	0.000116	0.000163	CcSEcCtD
Carbidopa—DDC—Metabolism—MTHFR—prostate cancer	0.000115	0.000423	CbGpPWpGaD
Carbidopa—Insomnia—Doxorubicin—prostate cancer	0.000115	0.000162	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—prostate cancer	0.000114	0.00016	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—prostate cancer	0.000113	0.000159	CcSEcCtD
Carbidopa—Feeling abnormal—Epirubicin—prostate cancer	0.000113	0.000159	CcSEcCtD
Carbidopa—DDC—Metabolism—PPARA—prostate cancer	0.000113	0.000415	CbGpPWpGaD
Carbidopa—Somnolence—Doxorubicin—prostate cancer	0.000113	0.000159	CcSEcCtD
Carbidopa—Gastrointestinal pain—Epirubicin—prostate cancer	0.000112	0.000158	CcSEcCtD
Carbidopa—Dyspepsia—Doxorubicin—prostate cancer	0.000112	0.000157	CcSEcCtD
Carbidopa—Vomiting—Prednisone—prostate cancer	0.000111	0.000157	CcSEcCtD
Carbidopa—Rash—Prednisone—prostate cancer	0.000111	0.000156	CcSEcCtD
Carbidopa—Dermatitis—Prednisone—prostate cancer	0.00011	0.000156	CcSEcCtD
Carbidopa—Decreased appetite—Doxorubicin—prostate cancer	0.00011	0.000155	CcSEcCtD
Carbidopa—Headache—Prednisone—prostate cancer	0.00011	0.000155	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.00011	0.000154	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—prostate cancer	0.000109	0.000154	CcSEcCtD
Carbidopa—Urticaria—Epirubicin—prostate cancer	0.000109	0.000153	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—prostate cancer	0.000109	0.000153	CcSEcCtD
Carbidopa—Pain—Doxorubicin—prostate cancer	0.000109	0.000153	CcSEcCtD
Carbidopa—Abdominal pain—Epirubicin—prostate cancer	0.000108	0.000153	CcSEcCtD
Carbidopa—Body temperature increased—Epirubicin—prostate cancer	0.000108	0.000153	CcSEcCtD
Carbidopa—DDC—Metabolism—CAV1—prostate cancer	0.000106	0.00039	CbGpPWpGaD
Carbidopa—Feeling abnormal—Doxorubicin—prostate cancer	0.000105	0.000147	CcSEcCtD
Carbidopa—Nausea—Prednisone—prostate cancer	0.000104	0.000147	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000104	0.000146	CcSEcCtD
Carbidopa—Hypersensitivity—Epirubicin—prostate cancer	0.000101	0.000142	CcSEcCtD
Carbidopa—Urticaria—Doxorubicin—prostate cancer	0.000101	0.000142	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—prostate cancer	0.0001	0.000141	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—prostate cancer	0.0001	0.000141	CcSEcCtD
Carbidopa—Asthenia—Epirubicin—prostate cancer	9.84e-05	0.000139	CcSEcCtD
Carbidopa—Pruritus—Epirubicin—prostate cancer	9.7e-05	0.000137	CcSEcCtD
Carbidopa—DDC—Metabolism—PIK3CG—prostate cancer	9.66e-05	0.000355	CbGpPWpGaD
Carbidopa—Diarrhoea—Epirubicin—prostate cancer	9.38e-05	0.000132	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—prostate cancer	9.35e-05	0.000132	CcSEcCtD
Carbidopa—DDC—Metabolism—INS—prostate cancer	9.15e-05	0.000336	CbGpPWpGaD
Carbidopa—Asthenia—Doxorubicin—prostate cancer	9.1e-05	0.000128	CcSEcCtD
Carbidopa—Dizziness—Epirubicin—prostate cancer	9.07e-05	0.000128	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—prostate cancer	8.98e-05	0.000126	CcSEcCtD
Carbidopa—DDC—Metabolism—CREBBP—prostate cancer	8.96e-05	0.00033	CbGpPWpGaD
Carbidopa—Vomiting—Epirubicin—prostate cancer	8.72e-05	0.000123	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—prostate cancer	8.68e-05	0.000122	CcSEcCtD
Carbidopa—Rash—Epirubicin—prostate cancer	8.65e-05	0.000122	CcSEcCtD
Carbidopa—Dermatitis—Epirubicin—prostate cancer	8.64e-05	0.000122	CcSEcCtD
Carbidopa—Headache—Epirubicin—prostate cancer	8.59e-05	0.000121	CcSEcCtD
Carbidopa—DDC—Metabolism—PIK3CD—prostate cancer	8.49e-05	0.000312	CbGpPWpGaD
Carbidopa—Dizziness—Doxorubicin—prostate cancer	8.39e-05	0.000118	CcSEcCtD
Carbidopa—Nausea—Epirubicin—prostate cancer	8.15e-05	0.000115	CcSEcCtD
Carbidopa—Vomiting—Doxorubicin—prostate cancer	8.07e-05	0.000114	CcSEcCtD
Carbidopa—DDC—Metabolism—NOS3—prostate cancer	8.02e-05	0.000295	CbGpPWpGaD
Carbidopa—Rash—Doxorubicin—prostate cancer	8e-05	0.000113	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—prostate cancer	7.99e-05	0.000113	CcSEcCtD
Carbidopa—Headache—Doxorubicin—prostate cancer	7.95e-05	0.000112	CcSEcCtD
Carbidopa—Nausea—Doxorubicin—prostate cancer	7.54e-05	0.000106	CcSEcCtD
Carbidopa—DDC—Metabolism—PIK3CB—prostate cancer	7.4e-05	0.000272	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTGS2—prostate cancer	7.33e-05	0.00027	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTEN—prostate cancer	6.4e-05	0.000235	CbGpPWpGaD
Carbidopa—DDC—Metabolism—EP300—prostate cancer	6.1e-05	0.000224	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CA—prostate cancer	4.51e-05	0.000166	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AKT1—prostate cancer	3.69e-05	0.000136	CbGpPWpGaD
